Orexo US Inc. is a subsidiary of Orexo AB (publ.) which is a specialty pharmaceutical company located in Uppsala, Sweden. The US organization’s main mission is to commercialize the drug Zubsolv® (buprenorphine and naloxone) sublingual tablet (CIII) for treatment of opioid dependence on the American market. Additionally, Orexo US Inc. focuses on clinical development and regulatory issues.

Orexo US Inc. Corporate Governance

California Compliance Declaration

Code of Conduct

Comprehensive Compliance Policy

For compliance issues or concern, please call, +1-855-700-8355

Related US web pages:

www.zubsolv.com

www.rise-us.com

For information on Orexo AB (publ.), please visit the corporate website www.orexo.com.